EZZ Life Science Holdings Limited (EZZ.AX)
AUD 1.45
(-0.68%)
AUD 1.45
(-0.68%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 25.55 Million AUD | 44.85% |
| 2023 | 17.64 Million AUD | 23.66% |
| 2022 | 14.26 Million AUD | 18.5% |
| 2021 | 12.03 Million AUD | 3.52% |
| 2020 | 11.62 Million AUD | 298.99% |
| 2019 | 2.91 Million AUD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 20.29 Million AUD | 42.28% |
| 2024 FY | 25.55 Million AUD | 44.85% |
| 2024 Q4 | 25.55 Million AUD | 0.0% |
| 2024 Q2 | 20.29 Million AUD | 0.0% |
| 2023 Q1 | 14.97 Million AUD | 4.99% |
| 2023 FY | 17.64 Million AUD | 23.66% |
| 2023 Q4 | 14.26 Million AUD | -19.13% |
| 2023 Q3 | 17.64 Million AUD | 17.78% |
| 2023 Q2 | 14.97 Million AUD | 0.0% |
| 2022 Q1 | 11.75 Million AUD | -2.34% |
| 2022 FY | 14.26 Million AUD | 18.5% |
| 2022 Q4 | 14.26 Million AUD | 0.0% |
| 2022 Q3 | 14.26 Million AUD | 21.34% |
| 2022 Q2 | 11.75 Million AUD | 0.0% |
| 2021 Q1 | 6.32 Million AUD | 2.25% |
| 2021 FY | 12.03 Million AUD | 3.52% |
| 2021 Q3 | 12.03 Million AUD | 90.36% |
| 2021 Q4 | 12.03 Million AUD | 0.0% |
| 2021 Q2 | 6.32 Million AUD | 0.0% |
| 2020 Q4 | 6.18 Million AUD | 0.0% |
| 2020 FY | 11.62 Million AUD | 298.99% |
| 2020 Q1 | - AUD | 0.0% |
| 2020 Q3 | 6.18 Million AUD | 0.0% |
| 2019 FY | 2.91 Million AUD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| AdAlta Limited | 5.57 Million AUD | -358.496% |
| Biome Australia Limited | 8.27 Million AUD | -208.719% |
| Radiopharm Theranostics Limited | 72.03 Million AUD | 64.529% |
| Biotron Limited | 493.47 Thousand AUD | -5077.959% |
| Acrux Limited | 8.96 Million AUD | -185.083% |
| Alterity Therapeutics Limited | 19.22 Million AUD | -32.919% |
| Botanix Pharmaceuticals Limited | 112.46 Million AUD | 77.28% |
| BTC Health Limited | 5.14 Million AUD | -396.27% |
| Chimeric Therapeutics Limited | 15.27 Million AUD | -67.3% |
| CSL Limited | 56.93 Billion AUD | 99.955% |
| Clarity Pharmaceuticals Ltd | 154.62 Million AUD | 83.475% |
| Clinuvel Pharmaceuticals Limited | 231.12 Million AUD | 88.944% |
| Immutep Limited | 147.44 Million AUD | 82.671% |
| Memphasys Limited | 12.43 Million AUD | -105.565% |
| Neuren Pharmaceuticals Limited | 247.97 Million AUD | 89.696% |
| Noxopharm Limited | 6.78 Million AUD | -276.664% |
| Prescient Therapeutics Limited | 20.39 Million AUD | -25.299% |
| Race Oncology Limited | 20.22 Million AUD | -26.316% |
| Starpharma Holdings Limited | 36.81 Million AUD | 30.592% |
| Tissue Repair Ltd | 19.38 Million AUD | -31.782% |
| Anatara Lifesciences Ltd | 1.67 Million AUD | -1428.757% |
| Bio-Gene Technology Limited | 3.15 Million AUD | -708.712% |
| Zelira Therapeutics Limited | 5.18 Million AUD | -392.956% |
| Patrys Limited | 4.16 Million AUD | -513.997% |
| Orthocell Limited | 26.61 Million AUD | 3.995% |
| Imugene Limited | 151.39 Million AUD | 83.123% |
| PYC Therapeutics Limited | 91.23 Million AUD | 71.994% |
| Proteomics International Laboratories Limited | 10.87 Million AUD | -134.958% |
| Cynata Therapeutics Limited | 8.38 Million AUD | -204.615% |
| Arovella Therapeutics Limited | 13.28 Million AUD | -92.342% |
| Nanollose Limited | 241.95 Thousand AUD | -10460.809% |
| Invex Therapeutics Ltd | 6.12 Million AUD | -317.513% |
| NeuroScientific Biopharmaceuticals Limited | 5.43 Million AUD | -370.062% |
| Amplia Therapeutics Limited | 14.84 Million AUD | -72.124% |
| Island Pharmaceuticals Limited | 2.56 Million AUD | -896.384% |
| Nyrada Inc. | 5.9 Million AUD | -332.552% |
| Telix Pharmaceuticals Limited | 398.3 Million AUD | 93.585% |
| Dimerix Limited | 32.07 Million AUD | 20.346% |
| PharmAust Limited | 11.12 Million AUD | -129.684% |
| Hexima Limited | 2.26 Million AUD | -1026.132% |
| AnteoTech Limited | 9.38 Million AUD | -172.375% |
| Paradigm Biopharmaceuticals Limited | 27.39 Million AUD | 6.712% |
| Recce Pharmaceuticals Ltd | 6.36 Million AUD | -301.154% |
| Avecho Biotechnology Limited | 7.31 Million AUD | -249.104% |
| Actinogen Medical Limited | 21.31 Million AUD | -19.896% |
| Immuron Limited | 15.54 Million AUD | -64.322% |
| Argenica Therapeutics Limited | 16.37 Million AUD | -56.018% |